Literature DB >> 31529033

Galectin-8 in the onset of the immune response and inflammation.

María V Tribulatti1,2, Julieta Carabelli1,2, Cecilia A Prato1,2, Oscar Campetella1,2.   

Abstract

Galectins (Gals), a family of mammalian lectins, have emerged as key regulators of the immune response, being implicated in several physiologic and pathologic conditions. Lately, there is increasing data regarding the participation of Galectin-8 (Gal-8) in both the adaptive and innate immune responses, as well as its high expression in inflammatory disorders. Here, we focus on the pro- and anti-inflammatory properties of Gal-8 and discuss the potential use of this lectin in order to shape the immune response, according to the context.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B and T cell cooperation; adaptive immune response; autoimmune disorders; galectin–glycan interaction; innate immune response

Mesh:

Substances:

Year:  2020        PMID: 31529033     DOI: 10.1093/glycob/cwz077

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  10 in total

1.  Prognostic Value and Biological Function of Galectins in Malignant Glioma.

Authors:  Hongtao Zhu; Dan Liu; Lidong Cheng; Jingdian Liu; Guanghui Wang; Huan Li; Yang Zhang; Hailong Mi; Suojun Zhang; Kai Shu; Xingjiang Yu
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 2.  Galectin-8, cytokines, and the storm.

Authors:  Yehiel Zick
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

3.  Galectin-8 Enhances T cell Response by Promotion of Antigen Internalization and Processing.

Authors:  Cecilia Arahí Prato; Julieta Carabelli; Oscar Campetella; María Virginia Tribulatti
Journal:  iScience       Date:  2020-06-17

4.  Anti-inflammatory Role of Galectin-8 During Trypanosoma cruzi Chronic Infection.

Authors:  Adriano Bertelli; Liliana M Sanmarco; Carla A Pascuale; Miriam Postan; Maria P Aoki; María S Leguizamón
Journal:  Front Cell Infect Microbiol       Date:  2020-07-02       Impact factor: 5.293

5.  A Fish Galectin-8 Possesses Direct Bactericidal Activity.

Authors:  Tengfei Zhang; Shuai Jiang; Li Sun
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

6.  N-Glycan profiling of chondrocytes and fibroblast-like synoviocytes: Towards functional glycomics in osteoarthritis.

Authors:  Johannes Fuehrer; Katharina M Pichler; Anita Fischer; Alexander Giurea; Daniela Weinmann; Friedrich Altmann; Reinhard Windhager; Hans-Joachim Gabius; Stefan Toegel
Journal:  Proteomics Clin Appl       Date:  2021-03-12       Impact factor: 3.603

7.  The role of galectins‑1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review).

Authors:  Aleksandra Mielczarek-Palacz; Zdzisława Kondera-Anasz; Marta Smycz-Kubańska; Aleksandra Englisz; Aleksandra Janusz; Patrycja Królewska-Daszczyńska; Dominika Wendlocha
Journal:  Mol Med Rep       Date:  2022-03-16       Impact factor: 2.952

8.  Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors.

Authors:  Sjors van Klaveren; Jaka Dernovšek; Žiga Jakopin; Marko Anderluh; Hakon Leffler; Ulf J Nilsson; Tihomir Tomašič
Journal:  RSC Adv       Date:  2022-06-30       Impact factor: 4.036

9.  Plasma proteomic signature of the risk of developing mobility disability: A 9-year follow-up.

Authors:  Yusuke Osawa; Richard D Semba; Giovanna Fantoni; Julián Candia; Angélique Biancotto; Toshiko Tanaka; Stefania Bandinelli; Luigi Ferrucci
Journal:  Aging Cell       Date:  2020-03-10       Impact factor: 9.304

10.  circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma.

Authors:  Ya-Ping Xu; Ze-Ning Dong; Si-Wei Wang; Yi-Min Zheng; Chi Zhang; Ying-Qun Zhou; Yu-Jie Zhao; Yan Zhao; Feng Wang; Rui Peng; Mao-Chun Tang; Dou-Sheng Bai; Xiao-Yong Huang; Chuan-Yong Guo
Journal:  J Exp Clin Cancer Res       Date:  2021-09-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.